Premium
Mn(III) mixed‐ligand complexes with bis ‐pyrazolones and ciprofloxacin drug: synthesis, characterization and antibacterial activities
Author(s) -
Modi C.K.,
Jani D.H.
Publication year - 2011
Publication title -
applied organometallic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.53
H-Index - 71
eISSN - 1099-0739
pISSN - 0268-2605
DOI - 10.1002/aoc.1782
Subject(s) - chemistry , ligand (biochemistry) , ciprofloxacin , denticity , pyrazolones , metal ions in aqueous solution , metal , stereochemistry , medicinal chemistry , organic chemistry , antibiotics , receptor , biochemistry
The fluoroquinolone family member ciprofloxacin is well known for its drug design and coordinating ability towards metal ions. The coordination chemistry of this drug with metal ions of biological and pharmaceutical importance is of considerable interest. Novel Mn(III) mixed‐ligand complexes of ciprofloxacin with various bis ‐pyrazolone‐based dinegative bidentate ligands were synthesized and characterized on the basis of their physical properties, magnetic susceptibility measurements, (FT‐IR and electronic) spectral studies. The FAB‐mass spectrum of [Mn(A 9 )(L)(H 2 O) 2 ]·H 2 O [where H 2 A 9 = 4,4′‐( p ‐tolylmethylene) bis (3‐methyl‐1‐phenyl‐4,5‐dihydro‐1H‐pyrazol‐5‐ol) and HL = 1‐cyclopropyl‐6‐fluoro‐4‐oxo‐7‐(piperazin‐1‐yl)‐1,4‐dihydroquinoline‐3‐carboxylic acid] was determined. All the synthesized compounds were screened for their bioactivity. The mixed‐ligand complexes exhibited comparable activities against two Gram‐negative ( Escherichia coli and Serratia marcescens ) and two Gram‐positive ( Staphylococcus aureus and Bacillus subtilis ) microorganisms. Copyright © 2011 John Wiley & Sons, Ltd.